SLIDESHOW: Ten Bargains You Can Buy Cheaper Than The Insiders
| This Slide: #1 of 10 |
(1) OptiNose Inc (NASDAQ:OPTN) triggered: 09/20/2018
OptiNose is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. Co.'s lead product includes XHANCE, a therapeutic product utilizing its proprietary breath powered exhalation delivery system that delivers a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps. Co. also markets AVP-825 for the acute treatment of migraines in adults through its license agreement with Avanir Pharmaceuticals, Inc.
OPTN — last trade: $13.57 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 06/08/2018 | Robert P. O'neil | Director | 2,000 | $22.75 | $45,500 |
| 08/15/2018 | Peter K. Miller | Chief Executive Officer | 10,752 | $14.32 | $153,969 |
| 08/15/2018 | Thomas Edward Gibbs | Chief Commercial Officer | 2,000 | $12.69 | $25,380 |
|
|||||||||||||||||||||
Read full article in a new window: Snatch This Bargain Even Cheaper Than Chief Executive Officer Miller Did
Open the OPTN Videos Page (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.80 out of 4) 80th percentile
(ranked higher than approx. 80% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
